BAUSCH HEALTH COMPANIES INC. (BHC)
Clinical trial NCT06803654: enrollment: not set → 578 participants.
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Clinical trial NCT05607095 updates: 1. completion date: 2026-05-01 → 2027-05-01 2. primary completion date: 2026-05-01 → 2027-05-01 3. enrollment: not set → 30 participants
INTEGRATIVE HEALTH TECHNOLOGIES, INC. (IHTI)
Clinical trial NCT06052631 updates: 1. start date: 2026-06-01 → 2026-06-02 2. enrollment: not set → 16 participants
INNOVATION PHARMACEUTICALS INC. (IPIX)
Clinical trial NCT07571824 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 92 participants
ABBOTT LABORATORIES (ABT)
Clinical trial NCT06888687 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 160 participants
MOLECULAR PARTNERS AG (MLLCF)
Clinical trial NCT07604883: enrollment: not set → 200 participants.
ARGENX SE (ARGX)
Clinical trial NCT07194850: enrollment: not set → 24 participants.
NOVO NORDISK A S (NVO)
Clinical trial NCT07282613: enrollment: not set → 80 participants.
BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT06431815: enrollment: not set → 228 participants.
PFIZER INC (PFE)
Clinical trial NCT07527832 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 1000 participants